BEIGF
Price
$15.95
Change
-$3.06 (-16.10%)
Updated
Apr 9 closing price
Capitalization
34.81B
VRAX
Price
$0.77
Change
-$0.01 (-1.28%)
Updated
Aug 11, 03:44 PM (EDT)
Capitalization
3.4M
Interact to see
Advertisement

BEIGF vs VRAX

Header iconBEIGF vs VRAX Comparison
Open Charts BEIGF vs VRAXBanner chart's image
BeOne Medicines
Price$15.95
Change-$3.06 (-16.10%)
Volume$100
Capitalization34.81B
Virax Biolabs Group
Price$0.77
Change-$0.01 (-1.28%)
Volume$376
Capitalization3.4M
BEIGF vs VRAX Comparison Chart in %
Loading...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEIGF vs. VRAX commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEIGF is a Hold and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (BEIGF: $15.95 vs. VRAX: $0.78)
Brand notoriety: BEIGF and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEIGF: 100% vs. VRAX: 25%
Market capitalization -- BEIGF: $34.81B vs. VRAX: $3.4M
BEIGF [@Biotechnology] is valued at $34.81B. VRAX’s [@Biotechnology] market capitalization is $3.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEIGF’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • BEIGF’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEIGF is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VRAX’s TA Score shows that 3 TA indicator(s) are bullish.

  • VRAX’s TA Score: 3 bullish, 7 bearish.

Price Growth

BEIGF (@Biotechnology) experienced а 0.00% price change this week, while VRAX (@Biotechnology) price change was -7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEIGF($34.8B) has a higher market cap than VRAX($3.4M). BEIGF YTD gains are higher at: 13.766 vs. VRAX (-65.160). VRAX has higher annual earnings (EBITDA): -6.43M vs. BEIGF (-116.48M). BEIGF has more cash in the bank: 2.52B vs. VRAX (7.29M). VRAX has less debt than BEIGF: VRAX (380K) vs BEIGF (997M). BEIGF has higher revenues than VRAX: BEIGF (4.18B) vs VRAX (84.9K).
BEIGFVRAXBEIGF / VRAX
Capitalization34.8B3.4M1,022,327%
EBITDA-116.48M-6.43M1,811%
Gain YTD13.766-65.160-21%
P/E RatioN/AN/A-
Revenue4.18B84.9K4,918,728%
Total Cash2.52B7.29M34,532%
Total Debt997M380K262,368%
TECHNICAL ANALYSIS
Technical Analysis
BEIGFVRAX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
22%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
13%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGVT51.270.76
+1.50%
Ingevity Corp
WYNN106.43-0.80
-0.74%
Wynn Resorts Limited
BAND13.37-0.25
-1.84%
Bandwidth
HGBL2.00-0.08
-3.85%
Heritage Global
BIVI1.67-1.24
-42.61%
BioVie Inc

BEIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEIGF has been loosely correlated with ALZN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BEIGF jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
ALZN - BEIGF
37%
Loosely correlated
+4.68%
NCNA - BEIGF
29%
Poorly correlated
-1.83%
CING - BEIGF
28%
Poorly correlated
-0.95%
GNTA - BEIGF
28%
Poorly correlated
-2.35%
GOVX - BEIGF
26%
Poorly correlated
+1.43%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-0.78%
ALZN - VRAX
43%
Loosely correlated
+4.68%
GOVX - VRAX
41%
Loosely correlated
+1.43%
BVNKF - VRAX
27%
Poorly correlated
N/A
AURX - VRAX
27%
Poorly correlated
N/A
BEIGF - VRAX
26%
Poorly correlated
N/A
More